DoctorsProofNPPES directory · verify at state boards

Pulmonary Disease in Oxford, MS

3 verified pulmonary disease doctors in Oxford.

Pulmonologists diagnose and treat diseases of the lungs and respiratory system, such as asthma, COPD, and sleep apnea.

NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.

Verify a license at the Mississippi State Board of Medical Licensure

Dr. Robert Mceachern, MD

Pulmonary Disease

21 yrs NPPES
NPI 1164413407
2301 S LAMAR BLVD, SUITE #100, Oxford, MS 38655(662) 234-0119
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $990.15 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$990.15

Total received

39

Transactions

17

Paying companies

Top paying companies

AstraZeneca Pharmaceuticals LP$269.40
Jazz Pharmaceuticals Inc.$114.90
Boehringer Ingelheim Pharmaceuticals, Inc.$107.25
NOVARTIS PHARMACEUTICALS CORPORATION$78.91
Bayer HealthCare Pharmaceuticals Inc.$53.42
Merck Sharp & Dohme LLC$53.15

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 79th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Robert Mceachern do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Jeffrey Evans, MD

Pulmonary Disease

20 yrs NPPES
NPI 1053414326
2301 SOUTH LAMAR BLVD SUITE 100, 2301 SOUTH LAMAR BLVD SUITE 100, Oxford, MS 38655(662) 234-0119
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $1,803 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$1,803

Total received

76

Transactions

21

Paying companies

Top paying companies

GlaxoSmithKline, LLC.$328.36
Inspire Medical Systems, Inc.$274.49
Harmony Biosciences LLC$186.12
Boehringer Ingelheim Pharmaceuticals, Inc.$113.02
Mylan Specialty L.P.$102.90
Insmed, Inc.$100.76

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 85th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Jeffrey Evans do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Jennifer Gardner, DO

Pulmonary Disease

19 yrs NPPES
NPI 1447450622
2301 SOUTH LAMAR, SUITE 100, Oxford, MS 38655(662) 234-0119
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $1,182 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$1,182

Total received

59

Transactions

17

Paying companies

Top paying companies

GlaxoSmithKline, LLC.$345.55
Regeneron Healthcare Solutions, Inc.$114.41
Boehringer Ingelheim Pharmaceuticals, Inc.$105.71
Grifols USA, LLC$81.40
United Therapeutics Corporation$71.22
Medtronic, Inc.$70.34

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 81th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Jennifer Gardner do not imply any wrongdoing. Many are meals, education, or research support.

Pulmonary Disease in Oxford, MS — Verified | DoctorsProof | DoctorsProof